Grown Rogue International (GRUSF) Cash & Equivalents (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Cash & Equivalents came in at $13.7 million in Q1 2026, up 106.32% year-on-year from $6.6 million in Q1 2025, and up 20.48% quarter-over-quarter from $11.4 million in Q4 2025.

Grown Rogue International (GRUSF) Cash & Equivalents (2009 - 2026) Analysis & Trends

Grown Rogue International's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $13.7 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 106.32% year-over-year to $13.7 million in Q1 2026; TTM through Mar 2026 was $13.7 million, a 106.32% increase from a year earlier, with the FY2025 full-year figure at $11.4 million, up 131.24% from the prior year.
  • Cash & Equivalents advanced to $13.7 million in Q1 2026 per GRUSF's latest filing, from $11.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $9252242000.0 billion in Q2 2025 and bottomed at $1.19 in Q4 2022.
  • The 5-year median for Cash & Equivalents is $5.9 million (2024), against an average of $578265943.4 billion.
  • Across the five-year window, Cash & Equivalents tumbled 100.0% in 2022 and soared 168236167789635.1% in 2025, its largest moves.
  • Year by year, Cash & Equivalents stood at $1.19 in 2022, then jumped by 419534249.68% to $5.0 million in 2023, then plunged by 32.94% to $3.4 million in 2024, then soared by 239.28% to $11.4 million in 2025, then gained by 20.48% to $13.7 million in 2026.
  • Per Business Quant, the three latest GRUSF Cash & Equivalents figures stand at $13.7 million (Q1 2026), $11.4 million (Q4 2025), and $13094.1 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.28 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 13.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.70 Mn
Dec 31, 2025 11.37 Mn
Sep 30, 2025 13,094.09 Bn
Jun 30, 2025 9,252,242,000.00 Bn
Mar 31, 2025 6.64 Mn
Dec 31, 2024 3.35 Mn
Sep 30, 2024 4.10 Mn
Jun 30, 2024 5.50 Mn
Mar 31, 2024 7.02 Mn
Dec 31, 2023 5.00 Mn
Oct 31, 2023 6.53 Mn
Jul 31, 2023 6.36 Mn
Apr 30, 2023 3.79 Mn
Jan 31, 2023 1.58 Mn
Oct 31, 2022 1.19
Jan 31, 2022 1.11 Mn
Oct 31, 2021 886,143.93
Jul 31, 2021 217,788.00
Apr 30, 2021 1.72 Mn
Jan 31, 2021 1.28 Mn